Related Experiment Videos
CHLVPP therapy for Hodgkin's disease identification of prognostic factors
1Department of Internal Medicine, University of Nebraska, Medical Center, Omaha, USA.
Leukemia & Lymphoma
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.
Bone marrow transplantation·2014
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
CD74 in hematological malignancies: from MHC chaperone to therapeutic target.
Leukemia & lymphoma·2026
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Drug design, development and therapy·2026
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.
Molecular therapy. Nucleic acids·2026
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.
Molecular therapy. Nucleic acids·2026